window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Delivery & Formulation

  • Drug Delivery & Formulation,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development

    Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

    April 18, 2026
  • Central Nervous System,Clinical Development,Drug Delivery & Formulation,Drug Development,Neurosciences,Patient Centricity

    Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome

    Emalex Biosciences has secured a US patent for an orally [...]

    April 11, 2026
  • Biotech,Drug Delivery & Formulation,Drug Development,Partnerships & Funding,Pharmaceuticals and therapeutics

    Bio-Sourcing and Tiny Cargo partner to develop oral monoclonal antibodies using milk exosomes

    Bio-Sourcing and Tiny Cargo will develop oral monoclonal antibody therapies [...]

    March 30, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Manufacturing,Partnerships & Funding

    Thermo Fisher and SHL Medical partner on integrated drug-device manufacturing in US

    Thermo Fisher Scientific and SHL Medical partner to integrate fill-finish, [...]

    March 27, 2026
  • Clinical studies,Digital Health,Drug Delivery & Formulation,Neurosciences

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    February 25, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Delivery & Formulation,European biotech,Facilities and infrastructure,Healthcare leadership,Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics

    Axplora expands lyophilisation capacity at Le Mans

    Axplora is investing several million euros to expand lyophilisation capacity [...]

    February 19, 2026
  • Chronic diseases,Drug approval,Drug Delivery & Formulation,Immunology,Pharmaceuticals and therapeutics,Respiratory

    Exdensur approved by European Commission for severe asthma and chronic rhinosinusitis with nasal polyps

    GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

    February 18, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Facilities and infrastructure,Ingredients,Manufacturing,Technology and platforms

    DFE Pharma launches continuous manufacturing platform with Gericke to support formulation development

    DFE Pharma has launched a new continuous manufacturing platform in [...]

    February 18, 2026
  • Central Nervous System,Chronic diseases,Clinical Development,Clinical Trials,Drug Delivery & Formulation,Drug Development,Pharmaceuticals and therapeutics,Respiratory

    Positive Phase 3 KALOS and LOGOS trial results for Breztri published in The Lancet Respiratory Medicine

    Full results from the Phase 3 KALOS and LOGOS trials [...]

    February 13, 2026
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Pharmaceuticals and therapeutics,Research & Development

    AmacaThera named Life Sciences Ontario emerging company of the year

    AmacaThera has been named Emerging Company of the Year by [...]

    February 13, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top